Provided by Tiger Fintech (Singapore) Pte. Ltd.

Olema Pharmaceuticals, Inc.

4.38
-0.0800-1.79%
Post-market: 4.380.00000.00%17:52 EDT
Volume:790.51K
Turnover:3.45M
Market Cap:299.69M
PE:-2.25
High:4.59
Open:4.51
Low:4.26
Close:4.46
Loading ...
Dec 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 10, 2024

Major Issues Report

Form 8-K - Current report
Dec 04, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Dec 02, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Sep 27, 2024

Major Issues Report

Form 8-K - Current report
Aug 06, 2024

Major Issues Report

Form 8-K - Current report
Aug 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 02, 2024

Major Issues Report

Form 8-K - Current report
Jun 28, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 14, 2024

Major Issues Report

Form 8-K - Current report
Jun 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities